Japan colorectal tumor prevention study: randomized controlled trial of curcumin

ABSTRACT: Interventions: curucmin 360mg/day placebo Primary outcome(s): The occurrence of a colorectal tumor (adenoma or cancer) is selected as the primary endpoint. Study Design: Parallel Randomized

DISEASE(S): Colorectal Tumor

PROVIDER: 2634115 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR